Cargando…

Development and validation of a novel circular RNA as an independent prognostic factor in acute myeloid leukemia

BACKGROUND: Although there are many clinical and molecular biomarkers in acute myeloid leukemia (AML), the novel and reliable biomarkers are still required to predict the overall survival at the time of disease diagnosis. METHODS: In order to identify independent predictors, we firstly selected 60 c...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wang, Jinghan, Pan, Jiajia, Huang, Shujuan, Li, Fenglin, Huang, Jiansong, Li, Xia, Ling, Qing, Ye, Wenle, Wang, Yungui, Yu, Wenjuan, Jin, Jie
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2021
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7849103/ https://www.ncbi.nlm.nih.gov/pubmed/33517886 http://dx.doi.org/10.1186/s12916-020-01898-y

Ejemplares similares

Inhibition of CPT1a as a prognostic marker can synergistically enhance the antileukemic activity of ABT199
por: Mao, Shihui, et al.
Publicado: (2021)

High Expression of TET1 Predicts Poor Survival in Cytogenetically Normal Acute Myeloid Leukemia From Two Cohorts
por: Wang, Jinghan, et al.
Publicado: (2018)

Homoharringtonine is synergistically lethal with BCL-2 inhibitor APG-2575 in acute myeloid leukemia
por: Wei, Wenwen, et al.
Publicado: (2022)

Global, regional, and national burdens of leukemia from 1990 to 2017: a systematic analysis of the global burden of disease 2017 study
por: Lin, Xiangjie, et al.
Publicado: (2021)

Abivertinib synergistically strengthens the anti‐leukemia activity of venetoclax in acute myeloid leukemia in a BTK‐dependent manner
por: Huang, Shujuan, et al.
Publicado: (2020)

High PARP-1 expression predicts poor survival in acute myeloid leukemia and PARP-1 inhibitor and SAHA-bendamustine hybrid inhibitor combination treatment synergistically enhances anti-tumor effects
por: Li, Xia, et al.
Publicado: (2018)

Dihydropyrimidinase‐like 2 can serve as a novel therapeutic target and prognostic biomarker in acute myeloid leukemia
por: Li, Fenglin, et al.
Publicado: (2023)

Low expression of ACLY associates with favorable prognosis in acute myeloid leukemia
por: Wang, Jinghan, et al.
Publicado: (2019)

Prognostic impact of MYH9 expression on patients with acute myeloid leukemia
por: Yu, Mengxia, et al.
Publicado: (2016)

Prognostic significance of huntingtin interacting protein 1 expression on patients with acute myeloid leukemia
por: Wang, Jinghan, et al.
Publicado: (2017)

MAP4K1 functions as a tumor promotor and drug mediator for AML via modulation of DNA damage/repair system and MAPK pathway
por: Ling, Qing, et al.
Publicado: (2021)

ACC010, a novel BRD4 inhibitor, synergized with homoharringtonine in acute myeloid leukemia with FLT3 ‐ITD
por: Qian, Yu, et al.
Publicado: (2023)

Leukemia stem cell-bone marrow microenvironment interplay in acute myeloid leukemia development
por: Yao, Yiyi, et al.
Publicado: (2021)

Spermatogenesis associated serine rich 2 like plays a prognostic factor and therapeutic target in acute myeloid leukemia by regulating the JAK2/STAT3/STAT5 axis
por: Li, Fenglin, et al.
Publicado: (2023)

Clinical Features and Prognostic Significance of NOTCH1 Mutations in Diffuse Large B-Cell Lymphoma
por: Li, Zhongqi, et al.
Publicado: (2021)

CEBPE expression is an independent prognostic factor for acute myeloid leukemia
por: Li, Kening, et al.
Publicado: (2019)

HES1 is an independent prognostic factor for acute myeloid leukemia
por: Tian, Chen, et al.
Publicado: (2015)

The combination effect of homoharringtonine and ibrutinib on FLT3-ITD mutant acute myeloid leukemia
por: Li, Xia, et al.
Publicado: (2017)

Platelet integrin αIIbβ3: signal transduction, regulation, and its therapeutic targeting
por: Huang, Jiansong, et al.
Publicado: (2019)

Correction: The combination effect of homoharringtonine and ibrutinib on FLT3-ITD mutant acute myeloid leukemia
por: Li, Xia, et al.
Publicado: (2019)

The specific distribution pattern of IKZF1 mutation in acute myeloid leukemia
por: Zhang, Xiang, et al.
Publicado: (2020)

Circular RNAs in acute myeloid leukemia
por: Singh, Vijendra, et al.
Publicado: (2021)

Identification and validation of potential prognostic gene biomarkers for predicting survival in patients with acute myeloid leukemia
por: Huang, Rui, et al.
Publicado: (2017)

The prognostic relevance and expression of progranulin in adult patients with acute myeloid leukemia
por: Qin, Jiajia, et al.
Publicado: (2020)

Identification of RHOBTB2 aberration as an independent prognostic indicator in acute myeloid leukemia
por: Liu, Peng, et al.
Publicado: (2021)

Development and Validation of an Individualized Metabolism-Related Prognostic Model for Adult Acute Myeloid Leukemia Patients
por: Wei, Cong, et al.
Publicado: (2022)

Prognostic Value of MicroRNA-20b in Acute Myeloid Leukemia
por: Cheng, Zhiheng, et al.
Publicado: (2021)

Recent Progress on Circular RNA Research in Acute Myeloid Leukemia
por: Jamal, Muhammad, et al.
Publicado: (2019)

Wilms Tumor 1 Mutations Are Independent Poor Prognostic Factors in Pediatric Acute Myeloid Leukemia
por: Wang, Yin, et al.
Publicado: (2021)

Acute myeloid leukemia with CPSF6–RARG fusion resembling acute promyelocytic leukemia with extramedullary infiltration
por: Han, Xiaoyan, et al.
Publicado: (2021)

Coronaviruses RNA interacts with host miR-500a-5p and miR-501-5p to regulate multiple pathways
por: Guo, Qi, et al.
Publicado: (2022)

Circular RNAs and Untranslated Regions in Acute Myeloid Leukemia
por: Yeh, Shih-Chia, et al.
Publicado: (2023)

Identification of prognostic genes in the acute myeloid leukemia microenvironment
por: Huang, Shaoxin, et al.
Publicado: (2019)

Evaluating the prognostic value of CD56 in pediatric acute myeloid leukemia
por: Liang, Tianqi, et al.
Publicado: (2022)

Functions and clinical significance of circular RNAs in acute myeloid leukemia
por: Zhou, Min, et al.
Publicado: (2022)

lncRNA co-expression network model for the prognostic analysis of acute myeloid leukemia
por: Pan, Jia-Qi, et al.
Publicado: (2017)

Identification and validation of a prognostic risk-scoring model based on the level of TIM-3 expression in acute myeloid leukemia
por: Huang, Wanxue, et al.
Publicado: (2023)

Development and Validation of a Novel Prognostic Model for Acute Myeloid Leukemia Based on Immune-Related Genes
por: Li, Ran, et al.
Publicado: (2021)

Distinct N7-methylguanosine profiles of circular RNAs in drug-resistant acute myeloid leukemia
por: Fu, Jinqiu, et al.
Publicado: (2023)

Nucleophosmin mutations confer an independent favorable prognostic impact in 869 pediatric patients with acute myeloid leukemia
por: Xu, Lu-Hong, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_qt2v7jr1jcgt6moqfqrj3o1li9